A garlic-derived exosome granule wound dressing and its preparation method and application

Through garlic-source exosome granule wound dressing, combined with Pluronic F127 hydrogel, ABTS and HRP, the detection complexity of Staphylococcus aureus infection and the poor absorption of antibiotics in host cells were solved, and the visualization of wound infection was achieved. Detection and effective antibacterial effects reduce toxic and side effects.

CN118079072BActive Publication Date: 2024-11-08SOUTHEAST UNIV
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
CN202410048999.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-12
Publication Date
2024-11-08
Estimated Expiration
2044-01-12

AI Technical Summary

Technical Problem

The existing methods for detecting Staphylococcus aureus infection are complex and inconvenient for on-site use, and antibiotics are difficult to effectively inhibit bacteria in host cells, resulting in complex treatment and prone to toxic and side effects and drug resistance.

Method used

Using garlic-source exosome granules wound dressing, containing antibiotic-loaded garlic-source exosome granules, Pluronic F127 hydrogel, ABTS and HRP, infection detection is performed through chromogenic reactions, and antibiotics are slowly released at the wound to improve Cell internalization.

Benefits of technology

Visual detection of wound infection and effective antibacterial inhibition are achieved, the amount of antibiotics used and toxic side effects are reduced, and the cellular internalization and antibacterial effect of antibiotics are significantly improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004662196860000011
    Figure HDA0004662196860000011
  • Figure HDA0004662196860000012
    Figure HDA0004662196860000012
  • Figure HDA0004662196860000021
    Figure HDA0004662196860000021
Patent Text Reader

Abstract

The invention discloses a garlic-derived exosome granule wound dressing and a preparation method and application thereof. The garlic-derived exosome granule wound dressing (Gel Van@GELNs) comprises garlic-derived exosome granules (Van@GELNs) loaded with antibiotics, hydrogel, 2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt and horseradish peroxidase. The 2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt in the dressing and H2O2 overexpressed at the wound infection site are green under the catalysis of horseradish peroxidase to realize the visual detection of Staphylococcus aureus infection. Meanwhile, Gel Van@GELNs continuously releases Van@GELNs at the wound infection site, and Van@GELNs can be delivered into infected cells through cell membranes and release Van, thereby realizing the treatment of intracellular Staphylococcus aureus infection and enhancing its effect in treating refractory infectious-related diseases.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biotechnology, and in particular relates to a garlic-derived exosome granule wound dressing, a preparation method and an application thereof. Background Art

[0002] In recent years, plant-derived exosome particles (ELNs) isolated from edible plants such as grapefruit, ginger, carrots, and lemons have attracted increasing attention. ELNs are naturally produced and carry functional substances such as small molecules, proteins, mRNA, and miRNA in plant cells. Some ELNs can treat specific diseases or maintain healthy body functions by regulating gene / protein expression in recipient cells, regulating the intestinal microbiome and homeostasis, promoting intestinal tissue regeneration, and exerting anti-tumor and anti-inflammatory effects. ELNs have greater potential in drug delivery due to their higher stability, superior biocompatibility, and greater encapsulation capacity of bioactive molecules. In addition, ELNs have the advantages of being non-toxic, low immunogenicity, and able to cross the blood-brain barrier (BBB). Garlic is rich in bioactive compounds, including allicin, diallyl disulfide, and quercetin, which play a key role in plant defense against pathogens and have good antimicrobial activity. Song et al. found (Song, H.; Canup, BSB; Ngo, VL; Denning, TL; Garg, P.; Laroui, H. Internalization of Garlic-Derived Nanovesicles on Liver Cells is Triggered by Interaction With CD98. ACS Omega 2020, 5 (36), 23118-23128.) that mannose-specific binding protein II lectin is highly expressed on the surface of garlic-derived ELNs (GELNs), which can recognize and bind to CD98 receptors on the cell surface, thereby significantly promoting the cellular internalization of GELNs. GELNs also exhibit anti-inflammatory effects by downregulating pro-inflammatory factors on HepG2 cells. Therefore, GELNs not only have certain biological functions, but also have strong cellular internalization ability, which promotes potential drug delivery carriers.

[0003] Staphylococcus aureus (S. aureus), as a facultative anaerobe, can generate intracellular infection reservoirs in multiple types of host cells, such as dendritic cells, macrophages, and invasive cancer cells, leading to recurrent infectious diseases. It can also establish secondary infection foci in host cells. When host cells are engulfed by macrophages, S. aureus can evade the immune system, thereby achieving long-term colonization and proliferation in host cells. In addition, S. aureus infection can lead to chronic inflammation, and infected wounds are not easy to heal. Therefore, timely detection of S. aureus infection in wounds is necessary. Recently, many methods for detecting S. aureus infection have been reported, such as polymerase chain reaction (PCR) immunoassay, electrochemistry, surface enhanced Raman scattering (SERS), etc. PCR assay has high sensitivity but is susceptible to interference from impurities such as proteins, polysaccharides, or biomacromolecules from other bacteria. Immunological techniques mostly use antibodies to accurately capture pathogens, but they have been plagued by biological activity and low stability. All of these methods mentioned above are instrumented, which requires a real-time method to detect S. aureus infection on the spot.

[0004] Antibiotic therapy remains the first choice for combating intracellular S. aureus infections. However, due to their poor absorption, rapid clearance, and low intracellular accumulation, most antibiotics are ineffective against intracellular pathogens, especially S. aureus in host cells. In addition, the treatment of intracellular bacterial infections is complex and the treatment cycle is long, which can easily lead to toxic side effects and drug resistance. Despite great progress in the discovery of antibiotics, treating intracellular bacterial infections remains a major challenge. Therefore, simplified detection of bacterial infections and delivery of antibiotics to infected host cells, especially immune cells such as macrophages, are important strategies to improve antibiotic treatment of intracellular infections. Summary of the invention

[0005] Purpose of the invention: In order to solve the above technical problems, the present invention aims to provide a garlic-derived exosome granule wound dressing (Gel Van@GELNs). When the wound is infected with bacteria, the ABTS and HRP contained in the auxiliary materials can be used as color reaction substrates to realize visual detection of wound infection, thereby solving the problems of complicated and inconvenient detection methods in the past. On the other hand, the garlic-derived exosome granules (Van@GELNs) loaded with antibiotics can be slowly released at the wound site, and the garlic-derived exosome granules (GELNs) as antibiotic carriers can deliver antibiotics into infected host cells, thereby improving the cellular internalization of antibiotics, solving the problems of poor absorption, rapid clearance and low intracellular accumulation, enhancing the antibacterial effect, and at the same time reducing the amount of antibiotics used and reducing toxic side effects.

[0006] The present invention also provides a preparation method and application of a garlic-derived exosome granule wound dressing.

[0007] Technical solution: In order to achieve the above-mentioned purpose, the garlic-derived exosome granule wound dressing (GelVan@GELNs) of the present invention comprises garlic-derived exosome granules loaded with antibiotics, Pluronic F127 hydrogel solution, 2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt (ABTS) and horseradish peroxidase (HRP).

[0008] Furthermore, the concentration ratio of horseradish peroxidase (HRP), (2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt (ABTS) and garlic-derived exosome particles loaded with antibiotics (Van@GELNs) is 0.01: 0.01-0.02: 0.01-0.025 mg / mL.

[0009] Preferably, the concentration ratio of (2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt (ABTS), horseradish peroxidase (HRP) and garlic-derived exosome particles loaded with antibiotics (Van@GELNs) is 0.01:0.02:0.025 mg / mL.

[0010] Furthermore, the concentration of the hydrogel solution is 10-30 wt%.

[0011] Preferably, the concentration of the hydrogel solution is 25 wt %.

[0012] The preparation method of the garlic-derived exosome granule wound dressing (Gel Van@GELNs) of the present invention comprises the following steps:

[0013] (1) preparing garlic-derived exosome particles;

[0014] (2) co-incubating the exosome particles prepared in step (1) with antibiotics to obtain garlic-derived exosome particles loaded with antibiotics;

[0015] (3) Adding the antibiotic-loaded garlic-derived exosome particles prepared in step (2), 2,2-azobis(3-ethylbenzothiazole-6-sulfonic acid) diammonium salt (ABTS), and horseradish peroxidase (HRP) to the hydrogel solution and mixing evenly to obtain a garlic-derived exosome particle wound dressing.

[0016] Furthermore, the method for preparing garlic-derived exosome particles in step (1) is as follows: fresh garlic is peeled, an appropriate amount of phosphate buffer solution (PBS) is added to squeeze the juice, the juice is subjected to gradient centrifugation and ultra-high-speed centrifugation to obtain crudely purified garlic-derived exosome particles, and then subjected to sucrose density gradient centrifugation to obtain purified garlic-derived exosome particles.

[0017] Furthermore, the sucrose density gradient is 8% to 60%.

[0018] Furthermore, the antibiotic in step (2) is any one of vancomycin, gentamicin, linezolid, rifampicin, and ciprofloxacin.

[0019] Furthermore, in step (2), the concentration ratio of garlic-derived exosome particles to antibiotics is 1:0.2-1.2 mg / mL.

[0020] Application of the garlic-derived exosome granule wound dressing of the present invention in the preparation of a drug for inhibiting intracellular bacterial infection.

[0021] The garlic-derived exosome granule wound dressing of the present invention is used in the preparation of a medicine for treating and promoting wound healing.

[0022] Design principle: Figure 1 As shown, a mixed hydrogel containing thermosensitive Pluronic F127 hydrogel, garlic-derived exosome particles loaded with vancomycin, ABTS and HRP is used as a wound dressing. Pluronic F127 hydrogel is fluid at low temperatures. When the temperature rises to body temperature of 37°C, the solution turns into a gel with good adhesion. The garlic-derived exosome particles containing antibiotics can be used as natural endogenous carriers to achieve efficient internalization of antibiotics into cells, showing a better antibacterial effect than traditional antibiotic treatment. In addition, the ABTS contained in the wound reacts with H2O2 overexpressed at the wound infection site under the catalysis of HRP to monitor whether the wound is infected.

[0023] The present invention uses garlic-derived exosomes to load antibiotics for intracellular Staphylococcus aureus infection for the first time. Compared with the current treatment methods for intracellular Staphylococcus aureus infection, the antibiotics can be efficiently delivered into the infected host cells, enhancing the cellular internalization of the antibiotics, solving the problems of poor absorption, rapid clearance and low intracellular accumulation faced by current antibiotic treatments, and its antibacterial level is significantly higher than that of simple antibiotic treatment. At the same time, the present invention reduces the amount of antibiotics used in the treatment process and reduces toxic side effects.

[0024] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages:

[0025] 1. The garlic exosome granule wound dressing (Gel Van@GELNs) of the present invention is composed of thermosensitive Pluronic F127 hydrogel encapsulating garlic exosome granules loaded with antibiotics, ABTS and HRP. Among them, the thermosensitive F127 hydrogel has the characteristics of being a fluid at low temperature and a gel when the temperature rises to body temperature 37°C. When the wound is infected with bacteria, the ABTS in the gel undergoes a color reaction under the catalysis of HRP to achieve visual detection, and can quickly gel at the infected wound.

[0026] 2. After the wound dressing prepared by the present invention comes into contact with the infected wound surface, it can effectively, stably and slowly release the garlic-derived exosome particles loaded with antibiotics, thereby killing Staphylococcus aureus inside and outside the cells of the wound tissue. At the same time, when used, the dressing is safe and reliable, has good biocompatibility, and has a significant promoting effect on the healing of the wound surface.

[0027] 3. The preparation method of the present invention is relatively simple, easy to implement, safe and reliable. Moreover, the obtained finished product has obvious antibacterial effect on bacterial infection wound surface and has obvious promoting effect on wound healing.

[0028] 4. The in vivo and in vitro experimental results in the embodiments of the present invention show that free vancomycin is poorly absorbed, quickly cleared, and cannot effectively inhibit the growth of intracellular bacteria. However, after vancomycin is loaded with garlic-derived exosome particles, the inhibitory effect on intracellular bacteria is significantly improved, and it can be effectively used to treat infections caused by intracellular bacteria. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 This is a schematic diagram of the design principle of the garlic-derived exosome granule wound dressing of the present invention;

[0030] Figure 2 Preparation, purification and characterization of garlic-derived exosome particles (Van@GELNs) loaded with vancomycin;

[0031] Figure 3 The UV absorption spectra of vancomycin at different concentrations and the standard curve of absorbance at 280 nm;

[0032] Figure 4 The biocompatibility and intracellular antibacterial effect of Van@GELNs;

[0033] Figure 5 Preparation and concentration optimization of PluronicF127 hydrogel;

[0034] Figure 6 Visual detection and treatment of Gel Van@GELNs in wounds;

[0035] Figure 7 HE staining of the main organs of mice. DETAILED DESCRIPTION

[0036] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.

[0037] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources. Experimental methods without specific conditions specified in the examples are usually carried out under conventional conditions or under conditions recommended by the manufacturer.

[0038] BCA protein concentration detection kit: Jiangsu KeyGen Biotech Co., Ltd., KGB2101;

[0039] DMEM medium: Jiangsu KeyGen Biotech Co., Ltd., KGL1206;

[0040] Domestic fetal bovine serum (FBS): Zhejiang Tianhang Biotechnology Co., Ltd.;

[0041] Ultrafiltration tube (MW100kD): purchased from Merck, Germany, UFC203024;

[0042] CCK-8 kit: Jiangsu KeyGen Biotech Co., Ltd., KGA9305;

[0043] LB medium: Jiangsu KeyGen Biotechnology Co., Ltd., KGH2105;

[0044] Pluronic F127: purchased from Aladdin Reagent Co., Ltd. (Shanghai, China), P434421;

[0045] Horseradish peroxidase (HRP): purchased from MacLean (Shanghai, China), P815746;

[0046] 2,2-Azobis(3-ethylbenzothiazole-6-sulfonic acid) diammonium salt (ABTS): purchased from MacLean (Shanghai, China), A800764-1g;

[0047] Vancomycin (Van): purchased from MacLean (Shanghai, China), V871983;

[0048] Sucrose: purchased from Maclean (Shanghai, China), S818046;

[0049] Instruments used in the present invention include: laser confocal microscope (FV3000, Olympus Corporation, Japan); UV-visible spectrophotometer (Cary60, Agilent, Singapore); ultracentrifuge (Optima XE-90 Ultracentrifuge, Beckman, America); ultrasonic cleaner (Suzhou, China); nanoparticle analyzer (Malvern Zeta sizer 3000HS, Malvern); microplate reader (Multiskan GO, Thermo, America); biological safety cabinet (BHC-1300IIA2, Beijing Aertai Technology Co., China).

[0050] The abbreviations of technical terms in the present invention are as follows: ABTS: 2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt; HRP: horseradish peroxidase; Van@GELNs: vancomycin-loaded garlic-derived exosome particles;

[0051] Example 1

[0052] Extraction and identification of garlic-derived exosome-like particles (GELNs)

[0053] Purchase fresh garlic, peel the garlic skin, wash the garlic with deionized water, add it to phosphate buffered saline (0.01M PBS, pH=7.4), and grind it with a crusher. Then centrifuge the garlic juice at 1000g for 10 minutes, 5000g for 20 minutes, and 10000g for 30 minutes to remove tissue fibers, large particles and cell debris. Then ultracentrifuge the supernatant at 100000g for 90 minutes at 4°C, and resuspend the obtained precipitate with 0.01M PBS to obtain crudely extracted GELNs. The crudely extracted GELNs are separated and purified by sucrose density gradient centrifugation, that is, the resuspension is transferred to a sucrose density gradient (8% / 30% / 45% / 60%), and then ultracentrifuged at 100000g for 90 minutes at 4°C. Figure 2 As shown in a, GELNs were mainly deposited at the 30 / 45% interface of the sucrose gradient. The GELNs between the 30% / 45% layers were collected and washed three times with 0.01 M PBS (pH = 7.4) to obtain purified garlic-derived exosome-like particles, which were stored at -80 °C until use. Figure 2 a TEM image shows that GELNs are spherical nanoparticles with a complete membrane structure and a diameter of about 150 nm. The concentration of exosome particles was tested using a BCA protein concentration detection kit, and the concentration of garlic-derived exosome particles was tested at 1 mg / mL.

[0054] Example 2

[0055] Preparation of garlic-derived exosomes loaded with vancomycin (Van@GELNs)

[0056] For the preparation of Van@GELNs, 0.05 mL of GELNs prepared in Example 1 (at a concentration of 1 mg / mL), 0.5 mL of vancomycin Van at different concentrations (at concentrations of 0.2, 0.4, 0.6, 0.8, 1, 1.2 mg / mL) and 0.45 mL of 0.01 M PBS (pH = 7.4) were mixed. Vancomycin was loaded into GELNs by co-incubation, i.e., the mixed solution of GELNs and vancomycin at different concentrations was incubated at 37 ° C for 60 min. Finally, an ultrafiltration membrane (MW100 kD) was used to separate the unloaded vancomycin in the solution to obtain the above-mentioned Van@GELNs prepared by vancomycin at different concentrations.

[0057] Attached Figure 2 d shows that the amount of Van loaded per gram of GELNs (mVan / mGELNs) increases first and then tends to equilibrium with the increase of Van concentration in the mixed solution (0.1-0.6 mg / mL). When the Van concentration in the mixed solution is 0.5 mg / mL, it reaches a maximum value of 0.2 (g / g), and the encapsulation efficiency is 8.4%. Figure 2 bTEM images show that Van@GELNs still maintain a complete membrane structure, indicating that loading vancomycin does not destroy the membrane structure of garlic exosomes. The above results show that Van@GELNs have been successfully prepared. Subsequent experiments selected Van@GELNs prepared under optimal conditions (0.5mL vancomycin Van, concentration of 1mg / mL). At this time, the concentration of Van@GELNs was determined by BCA to be 1.0mg / mL.

[0058] The amount of Van in Van@GELNs was analyzed by UV-visible (UV-vis) spectrophotometry (Cary60, Agilent, Singapore). First, a standard solution of vancomycin (concentration of 1 mg / mL) was prepared, and then gradient dilutions (0.02, 0.04, 0.06, 0.08, and 0.1 mg / mL) were performed with 0.01 M PBS (pH = 7.4). Then, the UV absorption spectra of vancomycin solutions with different concentrations were measured, as shown in Figure 2. Figure 3As shown in a and 3b, with different concentrations (μg / mL) as the horizontal coordinate and different optical densities (OD) at a wavelength of 280nm as the vertical coordinate, a standard curve of vancomycin solutions with different concentrations was obtained. 10μL of Van@GELNs (concentration of 1.0mg / mL) prepared under optimal conditions was treated with 100KHz ultrasound for 30min and filtered with a 0.22μm filter membrane. Finally, as shown in the attached Figure 2 As shown in Figure c, the garlic-derived exosome particles loaded with vancomycin showed an absorption peak at 280 nm, further proving the successful preparation of Van@GELNs. In addition, by measuring the OD value of the filtrate at 280 nm, the content of vancomycin in Van@GELNs was 5 μg / mL according to the above standard curve, and the drug loading rate was calculated.

[0059] Take 10 μL of the Van@GELNs solution (concentration of 1.0 mg / mL) prepared under the optimal conditions of this example, dilute it with 990 μL of 0.01M PBS, and determine the van content by the above UV-vis method. Calculate the loading rate according to the formula: drug loading rate = (Van concentration in Van@GELNs / Van concentration in the co-incubation system) * 100%. The Van loading rate in the Van@GELNs sample was measured to be 8.4% ± 0.45%.

[0060] Example 3

[0061] Antibacterial activity of GELNs and Van@GELNs

[0062] In order to evaluate the extracellular antibacterial activity, the growth curve method was used. The culture medium of Staphylococcus aureus in the exponential growth phase was taken and diluted to 5×10 5 CFU / mL. The experiment was divided into four groups (0.01M PBS, GELNs, Van and Van@GELNs), and each group was set up for 3 parallel experiments. The Van concentration of the Van group was 5μg / mL, while the GELNs concentration of the GELNs and Van@GELNs groups (prepared under the optimal conditions of Example 2) was 0.025mg / mL (at this time, the Van concentration in Van@GELNs was calculated to be 5μg / mL by Example 2), and 0.01M PBS was used as the blank control group. The diluted Staphylococcus aureus (concentration of 5×10 5 CFU / mL) were co-cultured for 12 h under the above four treatment conditions. The OD values ​​of the different treatment groups at 600 nm were recorded every 4 h. Figure 2 As shown in Figure 5, the bacterial growth curves of different treatment groups showed that the drug resistance of Van@GELNs to Staphylococcus aureus increased by about 84.5%, which was significantly higher than that of GELNs (6.7%).

[0063] The agar disk diffusion method was used to further evaluate the antibacterial activity of the prepared materials. 6 CFU / mL) were evenly spread on LB solid agar plates. 10 μL of GELNs (concentration of 0.025 mg / mL), Van (concentration of 5 μg / mL) and Van@GELNs (concentration of 0.025 mg / mL, at this time, the Van concentration in Van@GELNs was 5 μg / mL calculated by Example 2) were added dropwise to sterile filter paper and placed on LB solid agar plates. 0.01 M PBS was used as a blank control group and incubated at 37°C for 12 h. Figure 2 f, the diameter of the zone of inhibition (ZOI) was measured with a ruler. The results showed that the GELNs isolated from garlic had weak antibacterial activity, but their antibacterial ability could be enhanced by loading the antibiotic Van.

[0064] Example 4

[0065] Application of Van@GELNs to treat intracellular S. aureus infection in mouse macrophages (RAW 264.7)

[0066] Before studying the intracellular antibacterial activity, the cytotoxicity of GELNs and Van@GELNs was determined by CCK-8 assay. Figure 4 a shows that the cell viability of GELNs and Van@GELNs (prepared under the optimal conditions in Example 2) in the concentration range of 0-100 μg / mL (the Van concentration in Van@GELNs is 0-20 μg / mL) for 24 h is greater than 95%. This shows that GELNs and Van@GELNs have almost no toxicity to cells, and Van loading does not cause cytotoxicity.

[0067] To achieve intracellular bacterial clearance, antimicrobial drugs should be effectively internalized by cells without affecting cell viability. Figure 4 The ability of cells to internalize Van@GELNs as shown in b was confirmed by confocal laser scanning microscopy (CLSM). The GELNs purified in Example 1 were stained with the fluorescent dye DiO at 37°C for 30 minutes, and then separated by ultrafiltration tube to obtain Dio-labeled garlic-derived exosome particles (Dio-GELNs). After Dio-GELNs were incubated with RAW 264.7 cells for 4 hours, aggregated green fluorescence was found in the cells under a confocal laser scanning microscopy, indicating that GELNs were enriched in RAW 264.7 cells, confirming that GELNs can be internalized into cells. Using the same method, Van@GELNs showed similar results, indicating that the ability of GELNs to enter cells was not affected after drug loading.

[0068] Then, RAW 264.7 cells infected with Staphylococcus aureus were used as a model for intracellular antibacterial research. The experiment was divided into four groups (0.01M PBS, GELNs, Van and Van@GELNs), and each group was designed with three parallel experiments. The Van concentration in the Van group was 5μg / mL, while the GELNs concentration in the GELNs and Van@GELNs groups was 0.025mg / mL (the Van concentration in Van@GELNs was 5μg / mL), and 0.01M PBS was used as a blank control group. The only difference was that the RAW 264.7 cells infected with Staphylococcus aureus (cell infection method: number of bacteria / number of cells = 20 / 1, incubated for 2 hours) were cultured with different treatment groups at 37°C and 5% CO2 for 10 hours. After the culture, the cells were washed twice with PBS. The cells were then lysed with Hanks buffered saline (HBSS) containing 0.1% bovine serum albumin (BSA) and 0.1% Triton-X 100, and the lysate was serially diluted in PBS solution containing 0.05% Tween-20. The number of viable intracellular bacteria was determined on LB agar plates. The results are shown in the attached figure. Figure 4 As shown in c and d, compared with the 0.01 M PBS control group, the number of intracellular bacteria treated with Van or Van@GELNs (the concentration of Van was 5 μg / mL) was reduced by 1.55 and 2.45 log, respectively. 10 CFU / mL, while the difference in the number of bacteria treated with GELNs was small (less than 10%). On the other hand, the above experimental results were further verified by laser confocal microscopy CLSM. Figure 4 As shown in Figure e, after 4 hours of culture in different experimental groups, a large number of dead bacteria (marked with red fluorescence) can be observed in the RAW 264.7 cells infected with Staphylococcus aureus treated with Van@GELNs. However, for the Van-treated group, a large number of live bacteria (marked with green fluorescence) were still present in the cells. This indicates that Van@GELNs has a significant inhibitory effect on intracellular Staphylococcus aureus in RAW264.7, while free Van has almost no inhibitory effect on intracellular Staphylococcus aureus. The results show that Van@GELNs have good cellular internalization ability and have a significant antibacterial effect. In addition, as shown in the attached Figure 4 f shows that during the 24-hour co-culture of Van (5 μg / mL) and Van@GELNs (0.025 mg / mL) with RAW 264.7 cells, the accumulation of van in the Van@GELNs-treated group increased over time and was significantly higher than that in the Van-treated group, which further explains why the intracellular antibacterial effect of Van@GELNs is better than that of Van. Figure 4As shown in g and h, the expression levels of inflammatory factors in RAW 264.7 cells infected with Staphylococcus aureus after Van@GELNs treatment were significantly upregulated in TNF-α and downregulated in IL-10. Similarly, the Van treatment group showed relatively weak inflammation relief ability, which was consistent with the Figure 4 Their intracellular antibacterial results were consistent with those in ce.

[0069] Example 5

[0070] Preparation of Gel Van@GELNs wound dressing

[0071] Weigh a certain amount of Pluronic F127 powder and dissolve it in deionized water at 4°C. Prepare Pluronic F127 solutions of different concentrations (10, 15, 20, 25, 30 wt%) under magnetic stirring and store at low temperature for later use. Take 2 mL of Pluronic F127 solutions of different concentrations in sample bottles and incubate them in water baths at different temperatures (4 and 37°C) for 30 seconds. The results are shown in the attached figure. Figure 5 As shown in ab, when the concentration of Pluronic F127 solution is lower than 25 wt %, it is difficult for the solution to form a gel at 37°C, so the optimal concentration of Pluronic F127 solution is 25 wt %.

[0072] For the preparation of Gel Van@GELNs, HRP, ABTS and Van@GELNs (prepared under the optimal conditions in Example 2) were added to a 25 wt % Pluronic F127 solution at final concentrations of 0.01, 0.02 and 0.025 mg / mL, respectively, and stirred and mixed at 4° C. to obtain Gel Van@GELNs.

[0073] Example 6

[0074] In vivo treatment of mice with Gel Van@GELNs

[0075] The antibacterial effect of the Gel Van@GELNs wound dressing prepared in Example 5 on infected wounds was evaluated in mice. After 7 days of adaptation training, BALB / c female mice (6 weeks old, weighing 18-22 g) were anesthetized with 1.5% chloral hydrate, and then a full-thickness circular skin wound with a diameter of 5 mm was formed on the dorsal side with a punch.

[0076] The mice were randomly divided into 4 groups, and the wounds of three groups were inoculated with 100 μL of Staphylococcus aureus suspension (concentration of 10 8CFU / mL) for 4h to establish a Staphylococcus aureus infected wound model. Afterwards, 100μL of Pluronic F127 hydrogel (concentration of 25wt%), Gel Van (0.5mg / kg, which contains 25wt% hydrogel and 5μg / mL Van) and Gel Van@GELNs prepared in Example 5 (5.0mg / kg) were used respectively. The other group was not infected with Staphylococcus aureus and was treated with 25wt% Pluronic F127 hydrogel as a negative blank. The hydrogels of different treatment groups were replaced once a day, and the color changes of the hydrogels at the infected wounds were photographed. After 5 days of feeding, the wound sizes of the mice treated with different groups were photographed. Figure 6 As shown in a, on the 5th day after infection, mice were killed and infected tissues were obtained for further bacterial colony count determination, histological analysis, and immunohistochemistry and immunofluorescence staining. For colony determination, a certain amount of infected tissue was taken in PBS, and the tissue was removed by low-speed centrifugation after one minute of ultrasound, and the supernatant was spread on LB agar plates after 10-fold gradient dilution. For histological, immunohistochemical and immunofluorescence analysis, the infected tissue was fixed with 4% PFA, embedded in paraffin, stained and analyzed under optical microscope or CLSM (FV3000, Olympus Corporation, Japan).

[0077] As attached Figure 6 As shown in b, due to the overexpression of H2O2 in the infected wound, the colorless Gel Van@GELNs at the wound turned green after infection with Staphylococcus aureus. The wound photos of mice on the 5th day are shown in the attached figure. Figure 6 As shown in c, Gel

[0078] Van@GELNs significantly reduced the infected tissue area in mice in the three treatments, indicating that Gel

[0079] Van@GELNs promoted wound healing as well as uninfected wounds in the negative control group. The mice were then sacrificed and plate colony counts were used to quantify the residual bacteria in the wounds. Figure 6 As shown in Figure d, the number of surviving bacteria in the Gel Van@GELNs group was significantly lower than that in the PBS group (~100 times) and the Gel-Van group (~10 times). The enhanced antibacterial activity of Gel Van@GELNs in vivo is mainly attributed to the fact that GELNs are excellent carriers for intracellular drug delivery, achieving intracellular Van accumulation. To further evaluate Gel Van@GELNs, as shown in Figure d, Figure 6e H&E staining was performed on the infected tissues after different treatments, and it was found that the number of inflammatory cells in the Gel Van@GELNs group was the lowest among the four groups. In addition, immunofluorescence and immunohistochemistry analysis showed that the expression of pro-inflammatory cytokines (TNF-α) was significantly inhibited and the expression of anti-inflammatory factors (IL-10) was promoted in the GelVan@GELNs group (see Appendix Figure 6 f). Finally, H&E staining of major organs (attached Figure 7 ) The results showed that the Gel Van@GELNs group showed no damage to the main organs of the mice compared with the healthy mice in the PBS group, indicating that Gel Van@GELNs has good biosafety in vivo. In summary, the above results show that Gel Van@GELNs is a good wound dressing for visual detection and inhibition of bacterial infection in vivo.

Claims

1. A garlic-derived exosome granule wound dressing, characterized in that: The garlic-derived exosome particle wound dressing comprises garlic-derived exosome particles loaded with antibiotics, Pluronic F127 hydrogel, 2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt and horseradish peroxidase.

2. The garlic-derived exosome granule wound dressing according to claim 1, characterized in that: The concentration ratio of the horseradish peroxidase, 2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt and the garlic-derived exosome particles loaded with antibiotics is 0.01: 0.01-0.02: 0.01-0.025 mg / mL.

3. The garlic-derived exosome granule wound dressing according to claim 1, characterized in that: The concentration of the hydrogel solution is 10-30 wt %.

4. A method for preparing the garlic-derived exosome granule wound dressing according to claim 1, characterized in that: The following steps are involved: (1) Preparation of garlic-derived exosome particles; (2) co-incubating the garlic-derived exosome particles prepared in step (1) with antibiotics to obtain garlic-derived exosome particles loaded with antibiotics; (3) Add the antibiotic-loaded garlic-derived exosomes prepared in step (2), 2,2-azobis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt, and horseradish peroxidase to the hydrogel solution and mix evenly to obtain a garlic-derived exosome granule wound dressing.

5. The method for preparing the garlic-derived exosome granule wound dressing according to claim 4, characterized in that: The method for preparing garlic-derived exosome particles in step (1) is as follows: fresh garlic is peeled, phosphate buffer solution is added and juice is extracted, the juice is subjected to gradient centrifugation and ultra-high-speed centrifugation to obtain crudely purified garlic-derived exosome particles, and then subjected to sucrose density gradient centrifugation to obtain purified garlic-derived exosome particles.

6. The method for preparing the garlic-derived exosome granule wound dressing according to claim 5, characterized in that: The sucrose density gradient is 8% to 60%.

7. The method for preparing the garlic-derived exosome granule wound dressing according to claim 4, characterized in that: The antibiotic in step (2) is any one of vancomycin, gentamicin, linezolid, rifampicin and ciprofloxacin.

8. The method for preparing the garlic-derived exosome granule wound dressing according to claim 4, characterized in that: In the step (2), the concentration ratio of garlic-derived exosome particles to antibiotics is 1:0.2-1.2 mg / mL.

9. Use of the garlic-derived exosome granule wound dressing according to claim 1 in the preparation of a drug for inhibiting intracellular bacterial infection.

10. Use of the garlic-derived exosome granule wound dressing according to claim 1 in the preparation of a drug for treating and promoting wound healing.

Citation Information

Patent Citations

  • Exosome and hyaluronic acid combined wound dressing, and preparation method and application thereof

    CN113509590A

  • Preparation method and application of supramolecule-macromolecule composite hydrogel material

    CN115678047A

  • Injectable hydrogel based on plant exosome as well as preparation method and application of injectable hydrogel

    CN116492475A

  • Garlic source exosome, preparation method and application

    CN116836908A

  • Curcuma longa exosome derived nanoparticles and antibacterial application thereof

    CN116920103A